Created in 2019
Country
France
Created in 2019
Country
France
Ervimmune
ErVaccine is developing a platform for the development of therapeutic cancer vaccines based on antigens expressed from human endogenous retroviruses (HERVs). HERVs are ancestrally-acquired viral elements which persist in the human microbiome (virome) and are activated in many cancer types